| MSIF JAPANESE EQUITY I (JPY) | RVI JAPÓN | 43,84% | 98,59% | 117,34% | 197,68% |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | RVI BIOTECNOLOGÍA | 43,83% | 17,15% | -23,05% | · |
| FIDELITY FUNDS-ASIA EQUITY ESG Y-ACC-EUR | RVI ASIA EX-JAPÓN | 43,82% | 53,29% | 29,43% | 149,84% |
| FIDELITY FUNDS-TECHNOLOGY OPPORTUNITIES E-ACC-EUR | RVI TECNOLOGÍA | 43,82% | 70,51% | 37,00% | · |
| BGF ASIAN DRAGON X2 USD | RVI ASIA EX-JAPÓN | 43,80% | 64,09% | 44,02% | · |
| M&G (LUX) ASIAN FUND USD C ACC | RVI ASIA EX-JAPÓN | 43,80% | 91,20% | 95,38% | 204,69% |
| AB FCP I-EMERGING MARKETS GROWTH PORTFOLIO A USD | RVI EMERGENTES CRECIMIENTO | 43,78% | 65,39% | 31,87% | 101,09% |
| ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE IT EUR | RVI TECNOLOGÍA | 43,78% | 74,94% | 47,25% | · |
| MAN JAPAN COREALPHA EQUITY I JPY | RVI JAPÓN | 43,77% | 75,61% | · | 188,42% |
| BGF WORLD GOLD I2 EUR (HEDGED) | RVI MATERIAS PRIMAS | 43,76% | 130,95% | 92,97% | 81,83% |
